Bradley J.G. Larson, MD

Northwest Georgia Oncology Centers, P.C. Bremen Cancer Center 200 Allen Memorial Dr.
Suite 202
Bremen, GA 30110
Phone: (770) 824-2222

Carrollton Cancer Center 157 Clinic Avenue
Carrollton, GA 30117
Phone: (770) 333-2220
Fax: (678) 581-7180

Bradley J.G. Larson, MD joined the cancer care team of Northwest Georgia Oncology Centers, P.C. (NGOC) upon completion of his Fellowship at the University of Florida in 2004.

Dr. Larson is actively involved in cancer research and clinical trials to find a cancer cure and provide his patients with the most advanced cancer treatment available in Georgia.

Dr. Larson provides patient-centered cancer care at NGOC’s Carrollton Cancer Center and Bremen Cancer Center.

Personal DataBirthplace: Minneapolis, MN
Undergraduate EducationBS with distinction, Zoology, 1993
University of Wisconsin-Madison
Medical EducationDoctor of Medicine
University of Wisconsin-Madison Medical School
1993 - 1997
Madison, WI
Internal Medicine
University of Florida, Gainesville, FL
1997 - 2000
Chief Resident, Internal Medicine, University of Florida

Clinical Hematology and Oncology
University of Florida, Gainesville, FL
2001 - 2004
Board CertificationAmerican Board of Internal Medicine, Medical Oncology, 2004
American Board of Internal Medicine, Hematology, Board Eligible
Medical LicensureState of Georgia, 2004 (Active)
Professional SocietiesMedical Association of Georgia
Georgia Society of Clinical Oncology
HonorsElection to College of Letters and Sciences Dean’s List, 1989, 1991
Peter and Emily Lound Scholarship, 1993
Recipient of Letter of Commendation for Academic Achievement, 1993, 1996
UW Medical Student Association Leadership Award, 1994, 1995
Student Leadership Award, 1995
“Resident of the Month” Department of Emergency Medicine, 1999
Senior Resident Teaching Award, 1999
Larson B, Waples J, Lynch J. A phase II study of patients with relapsed or refractory indolent non-Hodgkin’s lymphoma treated with Gemcitabine. American Journal of Clinical Oncology 28(2):165-168, 2005.

Larson B, Zumberg M, Kitchens C. A Feasibility Study of Continuing Dose- Reduced Warfarin for Invasive Procedures in Patients with High Thromboembolic Risk. Chest 127: 922-927, 2005.

Smock AL, Larson B, Brown C, Conti CR. Echocardiographic assessment of left ventricular function early after Q-wave Myocardial Infarction predicts thirty day prognosis. Clinical Cardiology 24(3): 191-195, 2001.

Larson B, Zumberg M, Kitchens C. A feasibility study of continuing dose-related warfarin for major surgery in patients with high thromboembolic risk. ASH Poster presentation; Abtract #1148, 2003

“CD 23 status predicts survival in atypical CLL”. ASH supplement, Astract 2000.
Major Research InterestsClinical Trials (Oncology & Hematology)